Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Aceclidine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4LENZ THERAP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    LENZ THERAP

    ACECLIDINE HYDROCHLORIDE

    arrow
    The MedTech Conference
    Not Confirmed

    LENZ THERAP

    U.S.A
    arrow
    The MedTech Conference
    Not Confirmed

    Patent Expiration Date : 2034-03-24

    ACECLIDINE HYDROCHLORIDE

    US Patent Number : 10052313

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 218585

    Patent Use Code : U-3741

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-03-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    LENZ THERAP

    ACECLIDINE HYDROCHLORIDE

    arrow
    Fall Technical Meeting
    Not Confirmed

    LENZ THERAP

    U.S.A
    arrow
    Fall Technical Meeting
    Not Confirmed

    Patent Expiration Date : 2034-03-24

    ACECLIDINE HYDROCHLORIDE

    US Patent Number : 9844537

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 218585

    Patent Use Code : U-3741

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-03-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    LENZ THERAP

    ACECLIDINE HYDROCHLORIDE

    arrow
    Fall Technical Meeting
    Not Confirmed

    LENZ THERAP

    U.S.A
    arrow
    Fall Technical Meeting
    Not Confirmed

    Patent Expiration Date : 2039-10-08

    ACECLIDINE HYDROCHLORIDE

    US Patent Number : 12128036

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 218585

    Patent Use Code : U-3741

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2039-10-08

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    LENZ THERAP

    ACECLIDINE HYDROCHLORIDE

    arrow
    Fall Technical Meeting
    Not Confirmed

    LENZ THERAP

    U.S.A
    arrow
    Fall Technical Meeting
    Not Confirmed

    Patent Expiration Date : 2034-03-24

    ACECLIDINE HYDROCHLORIDE

    US Patent Number : 11179328

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 218585

    Patent Use Code : U-3741

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2034-03-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF